Information:
Error:
ID
15652
Description
Alemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective Potential (ALAIN01) https://clinicaltrials.gov/ct2/show/NCT02419378 Principal Investigator Prof. Dr. Dr. Sven Meuth, University Hospital Muenster, Germany Part: Relapse Evaluation Visit No. 4
Link
https://clinicaltrials.gov/ct2/show/NCT02419378
Keywords
Versions (1)
- 6/6/16 6/6/16 -
Uploaded on
June 6, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Relapse Evaluation Visit No. 4: Recent Symptoms Multiple Sclerosis ALAIN01 NCT02419378
Relapse Evaluation Visit No. 4: Recent Symptoms Multiple Sclerosis ALAIN01 NCT02419378
Similar models
Relapse Evaluation Visit No. 4: Recent Symptoms Multiple Sclerosis ALAIN01 NCT02419378
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Patient ID (derived)
Item
Patient ID (derived)
text
C2348585 (UMLS CUI [1])
Recent symptoms
Item
Relapse: Recent symptoms description
text
C1457887 (UMLS CUI [1])
Symptoms Start Date
Item
Relapse: Recent symptoms Start Date
date
C1457887 (UMLS CUI [1,1])
C2826738 (UMLS CUI [1,2])
C2826738 (UMLS CUI [1,2])
Symptoms End Date
Item
Relapse: Recent symptoms End Date
date
C1457887 (UMLS CUI [1,1])
C2826747 (UMLS CUI [1,2])
C2826747 (UMLS CUI [1,2])
Item
Relapse: Recent symptoms ongoing
text
C1457887 (UMLS CUI [1,1])
C0150312 (UMLS CUI [1,2])
C0150312 (UMLS CUI [1,2])
CL Item
ongoing (1)